IJIMS.2015.118

Type of Article: Review

Volume 2; Issue 5 : May 2015

Page No.: 128-132

DOI: 10.16965/ijims.2015.118

 

St John’s Wort and Related Drug Interactions

Sujit Kumar Sarker *1, Ratna Paul 2, Himel Pal 3, Soe Wunna Shwe 1.

*1 Faculty of Medicine, International Medical School, Management & Science University, Shah Alam, Selangor, Malaysia.

2 Mohammadpur Fertility Services & Training Centre, Mohammadpur, Dhaka, Bangladesh.

3 Banaripara Upazila Health Complex, Banaripara, Barisal, Bangladesh.

 

CORRESPONDENCE: Sujit Kumar Sarker, Department of Pharmacology, Faculty of Medicine, International Medical School, Management & Science University, Seksyen-13, 40100 Shah Alam, Selangor, Malaysia. Mobile: +60142139129, E-Mail: sujit_swapna@yahoo.com; ssswapnasujit3@gmail.com

 

ABSTRACT

Introduction: St John’s wort (Hypericum perforatum L.) is a perennial plant that has transparent perforations on its leaves. It has been used as medicinal herb since ancient time.

Medicinal values: Many bioactive compounds have been isolated from St John’s wort. Among those compounds hypericin and hyperforin are well studied. Both have antidepressant effects. This herb has also antineoplastic, antiviral and many other effects. Oil macerates are also used in wound healing. St John’s wort extracts are used as complementary medicine in many countries.

Pharmacology: Few studies suggests that it inhibits monoamine oxidase and re-uptake of serotonin, dopamine and norepinephrine. But it causes induction of liver cytochrome oxidase enzymes and also causes many adverse effects including mania and photosensitivity.

Drug interactions: Most of the drug interactions occur due to its enzyme induction properties. It can also reduce plasma concentration of antidepressants like amitriptyline and SSRI. It increases serotonergic effects of antidepressants such as duloxetine and venlafaxine. Data suggests that it has significant interactions with antiepileptics, combined oral contraceptives, calcium channel blockers, lipid regulating drugs (statins), antivirals and many more.

Conclusion: Although most popular use of St John’s wort is mild to moderate depression, it should be taken under supervision of physician as many cases its concomitant uses are not advisable.

KEY WORDS: St John’s wort, Drug interactions.

 

REFERENCES

 

  1. Jane Mangold, Roger Sheley and Melissa Brown. St. Johnswort: identification, biology and integrated management. Montana State University Extension. [updated 2009 August] Available from: http://www.msuextension.org/invasiveplantsMangold/documents/ Publications_bulletins/St.%20Johnswort.pdf
  2. Pöldinger W. History of St. Johns wort. Praxis (Bern 1994) 2000;89(50):2102-9.
  3. [updated 2015 May 10] Available from: http://en.wikipedia.org/wiki/John_the_Baptist
  4. Vorbach EU, Arnoldt KH, Wolpert E. St John’s wort: a potential therapy for elderly depressed patients? Drugs Aging 2000;16(3):189-97.
  5. Istikoglou CI, Mavreas V, Geroulanos G. History and therapeutic properties of Hypericum Perforatum from antiquity until today. Psychiatriki 2010;21(4):332-8.
  6. Butterweck V. Mechanism of action of St John’s wort in depression : what is known? CNS Drugs 2003; 17(8):539-62.
  7. Murthy HN, Kim YS, Park SY, Paek KY. Hypericins: biotechnological production from cell and organ cultures. Appl Microbiol Biotechnol 2014;98(22):9187-98.
  8. Zanoli P. Role of hyperforin in the pharmacological activities of St. John’s Wort. CNS Drug Rev 2004; 10(3):203-18.
  9. Orhan IE, Kartal M, Gülpinar AR, Yetkin G, Orlikova B, Diederich M, Tasdemir D. Inhibitory effect of St. John׳s Wort oil macerates on TNFα-induced NF-κB activation and their fatty acid composition. J Ethnopharmacol 2014;155(2):1086-92.
  10. Müller WE.Current St John’s wort research from mode of action to clinical efficacy. Pharmacol Res. 2003;47(2):101-9.
  11. Pakseresht S, Boustani H, Azemi ME, Nilsaz J, Babapour R, Haghdust MR. Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur J Nat Pharm Prod 2012;7(3):106-10.
  12. Nierenberg AA, Burt T, Matthews J, Weiss AP. Mania associated with St. John’s wort. Biol Psychiatry 1999,46(12):1707-8.
  13. Fahmi M, Huang C, Schweitzer I. A case of mania induced by hypericum. World J Biol Psychiatry 2002;3(1):58-9.
  14. Güzelcan Y, Scholte WF, Assies J, Becker HE. Mania during the use of a combination preparation with St. John’s wort (Hypericum perforatum). Ned Tijdschr Geneeskd 2001;145(40):1943-5.
  15. Barnes J, Anderson LA, Phillipson JD. St John’s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001;53(5):583-600.
  16. Beattie PE, Dawe RS, Traynor NJ, Woods JA, Ferguson J, Ibbotson SH. Can St John’s wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy? Br J Dermatol 2005; 153(6):1187-91.
  17. Agollo MC, Miszputen SJ, Diament J. Hypericum perforatum-induced hepatotoxicity with possible association with copaiba (Copaifera langsdorffii Desf): case report. Einstein (Sao Paulo) 2014;12(3):355-7.
  18. Lampri ES, Ioachim E, Harissis H, Balasi E, Mitselou A, Malamou-Mitsi V: Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis. World J Gastroenterol 2014,20(8):2113-6.
  19. BMA & Royal Pharmaceutical Society. Appendix-1: Interactions. British National Formulary 2014;67: 245,955.
  20. John R. Horn. Important drug interactions and their mechanisms. In: Bertram G. Katzung, Susan B. Masters, Anthony J. Trevor, editors. Basic & Clinical Pharmacology. New York: Mc Graw Hill;2013.p1149-1162.
  21. drugus.com. St.John’s wort. [updated 2015 April 1]. Available from: http://www.drugs.com/cdi/st-john-s-wort.html
  22. USDA National Agricultural Library. St. Johnswort. [updated 2015 April 17]. Available from: http://www.invasivespeciesinfo.gov/plants/stjohnswort.shtml#cit
  23. Invasive plant atlas from the United States. Common St. Johnswort. [updated 2015 April 24]. Available from: http://www.invasiveplantatlas.org/subject.html?sub=4411
  24. Rx list. [updated 2015 May 13] Available from: http://www.rxlist.com/st_johns_wort/supplements.htm
  25. Knüppel L, Linde K. Adverse effects of St. John’s Wort: a systematic review. J Clin Psychiatry 2004;65(11):1470-9.
  26. Paul Hammerness, Ethan Basch, Catherine Ulbricht, E.-P. Barrette, Ivo Foppa, Samuel Basch et al., John’s Wort: A Systematic Review of Adverse Effects and Drug Interactions for the Consultation Psychiatrist. Psychosomatics 2003;44(4):271-282.
  27. Hina Laeeque, Theresa L. Charrois, Sunita Vohra. Adverse Effects and Drug Interactions Relating to Use of St. John’s Wort. Canadian Pharmacists Journal 2006;139:30-33.
  28. Klaus Linde, Michael Berner, Matthias Egger, Cynthia Mulrow. St John’s wort for depression: Meta-analysis of randomised controlled trials. British Journal of Phychiatry 2005;186:99-107.

 

Download Full Text TOC